-
Loading metrics
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
- B. A. S. Jaeger,
- J. Neugebauer,
- U. Andergassen,
- C. Melcher,
- F. Schochter,
- D. Mouarrawy,
- G. Ziemendorff,
- M. Clemens,
- E. v. Abel,
- G. Heinrich
x
- Published: June 6, 2017
- https://doi.org/10.1371/journal.pone.0173593